Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Cardiol J ; 28(4): 566-578, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34031866

RESUMO

BACKGROUND: To date, there is little information regarding management of patients with infective endocarditis (IE) that did not undergo an indicated surgery. Therefore, we aimed to evaluate prognosis of these patients treated with a long-term antibiotic treatment strategy, including oral long term suppressive antibiotic treatment in five referral centres with a multidisciplinary endocarditis team. METHODS: This retrospective, multicenter study retrieved individual patient-level data from five referral centres in Spain. Among a total of 1797, 32 consecutive patients with IE were examined (median age 72 years; 78% males) who had not undergone an indicated surgery, but received long-term antibiotic treatment (LTAT) and were followed by a multidisciplinary endocarditis team, between 2011 and 2019. Primary outcomes were infection relapse and mortality during follow-up. RESULTS: Among 32 patients, 21 had IE associated with prostheses. Of the latter, 8 had an ascending aorta prosthetic graft. In 24 patients, a switch to long-term oral suppressive antibiotic treatment (LOSAT) was considered. The median duration of LOSAT was 277 days. Four patients experienced a relapse during follow-up. One patient died within 60 days, and 12 patients died between 60 days and 3 years. However, only 4 deaths were related to IE. CONCLUSIONS: The present study results suggest that a LTAT strategy, including LOSAT, might be considered for patients with IE that cannot undergo an indicated surgery. After hospitalization, they should be followed by a multidisciplinary endocarditis team.


Assuntos
Endocardite Bacteriana , Endocardite , Idoso , Antibacterianos/uso terapêutico , Endocardite/diagnóstico , Endocardite/tratamento farmacológico , Endocardite/cirurgia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/cirurgia , Feminino , Humanos , Masculino , Prognóstico , Estudos Retrospectivos
2.
Rev. esp. cardiol. (Ed. impr.) ; 73(9): 734-740, sept. 2020. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-197858

RESUMO

INTRODUCCIÓN Y OBJETIVOS: En endocarditis infecciosa (EI), la decisión quirúrgica es difícil. Un alto porcentaje de pacientes con indicación quirúrgica no son intervenidos. El objetivo fue evaluar el pronóstico a corto y largo plazo de los pacientes con indicación quirúrgica, comparando los que se sometieron a cirugía con los que no lo hicieron. MÉTODOS: Se incluyeron 271 pacientes con EI izquierda e indicación quirúrgica tratados en el centro desde 2003 a 2018. Ochenta y tres pacientes (31%) no fueron finalmente operados. El objetivo primario fue la mortalidad a 60 días y el secundario desde el día 61 a los 3 años de seguimiento. Se realizó regresión de Cox multivariable y emparejamiento por puntuación de propensión. RESULTADOS: A los 60 días, 40 (21,3%) pacientes operados y 53 (63,9%) pacientes no intervenidos fallecieron (p <0,001). El riesgo de mortalidad a 60 días fue superior en los pacientes no intervenidos (HR = 3,59; IC95%, 2,16-5,96; p <0,001). La ausencia de diagnóstico microbiológico, la insuficiencia cardiaca, el shock y el bloqueo auriculoventricular fueron otros predictores independientes del objetivo primario. Del día 61 a los 3 años del seguimiento no hubo diferencias significativas del riesgo de muerte entre el grupo operado y los no intervenidos (HR = 1,89; IC95%, 0,68-5,19; p = 0,220). Las variables independientes asociadas con el objetivo secundario fueron los antecedentes de EI, diabetes mellitus y el índice de Charlson. Los resultados fueron consistentes tras el emparejamiento por puntuación de propensión. CONCLUSIONES: Dos tercios de los pacientes con indicación quirúrgica no intervenidos fallecieron antes de 60 días. Entre los supervivientes, la mortalidad a largo plazo depende más de factores relacionados con comorbilidad previa que del tratamiento recibido durante el ingreso


INTRODUCTION AND OBJECTIVES: In infective endocarditis (IE), decisions on surgical interventions are challenging and a high percentage of patients with surgical indication do not undergo these procedures. This study aimed to evaluate the short- and long-term prognosis of patients with surgical indication, comparing those who underwent surgery with those who did not. METHODS: We included 271 patients with left-sided IE treated at our institution from 2003 to 2018 and with an indication for surgery. There were 83 (31%) surgery-indicated not undergoing surgery patients with left-sided infective endocarditis (SINUS-LSIE). The primary outcome was all-cause death by day 60 and the secondary outcome was all-cause death from day 61 to 3 years of follow-up. Multivariable Cox regression and propensity score matching were used for the analysis. RESULTS: At the 60-day follow-up, 40 (21.3%) surgically-treated patients and 53 (63.9%) SINUS-LSIE patients died (P <.001). Risk of 60-day mortality was higher in SINUS-LSIE patients (HR, 3.59; 95%CI, 2.16-5.96; P <.001). Other independent predictors of the primary endpoint were unknown etiology, heart failure, atrioventricular block, and shock. From day 61 to the 3-year follow-up, there were no significant differences in the risk of death between surgically-treated and SINUS-LSIE patients (HR, 1.89; 95%CI, 0.68-5.19; P=.220). Results were consistent after propensity score matching. Independent variables associated with the secondary endpoint were previous IE, diabetes mellitus, and Charlson index. CONCLUSIONS: Two-thirds of SINUS-LSIE patients died within 60 days. Among survivors, the long-term mortality depends more on host conditions than on the treatment received during admission


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Endocardite Bacteriana/mortalidade , Procedimentos Cirúrgicos Cardíacos/estatística & dados numéricos , Infecções Relacionadas à Prótese/mortalidade , Endocardite Bacteriana/complicações , Efeitos Adversos de Longa Duração/epidemiologia , Prognóstico , Recusa do Paciente ao Tratamento/estatística & dados numéricos , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Estudos Prospectivos
3.
Rev Esp Cardiol (Engl Ed) ; 73(9): 734-740, 2020 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31767290

RESUMO

INTRODUCTION AND OBJECTIVES: In infective endocarditis (IE), decisions on surgical interventions are challenging and a high percentage of patients with surgical indication do not undergo these procedures. This study aimed to evaluate the short- and long-term prognosis of patients with surgical indication, comparing those who underwent surgery with those who did not. METHODS: We included 271 patients with left-sided IE treated at our institution from 2003 to 2018 and with an indication for surgery. There were 83 (31%) surgery-indicated not undergoing surgery patients with left-sided infective endocarditis (SINUS-LSIE). The primary outcome was all-cause death by day 60 and the secondary outcome was all-cause death from day 61 to 3 years of follow-up. Multivariable Cox regression and propensity score matching were used for the analysis. RESULTS: At the 60-day follow-up, 40 (21.3%) surgically-treated patients and 53 (63.9%) SINUS-LSIE patients died (P <.001). Risk of 60-day mortality was higher in SINUS-LSIE patients (HR, 3.59; 95%CI, 2.16-5.96; P <.001). Other independent predictors of the primary endpoint were unknown etiology, heart failure, atrioventricular block, and shock. From day 61 to the 3-year follow-up, there were no significant differences in the risk of death between surgically-treated and SINUS-LSIE patients (HR, 1.89; 95%CI, 0.68-5.19; P=.220). Results were consistent after propensity score matching. Independent variables associated with the secondary endpoint were previous IE, diabetes mellitus, and Charlson index. CONCLUSIONS: Two-thirds of SINUS-LSIE patients died within 60 days. Among survivors, the long-term mortality depends more on host conditions than on the treatment received during admission.


Assuntos
Endocardite Bacteriana , Endocardite , Endocardite/cirurgia , Endocardite Bacteriana/cirurgia , Mortalidade Hospitalar , Hospitalização , Humanos , Prognóstico , Estudos Retrospectivos , Sobreviventes
4.
Artigo em Espanhol | IBECS | ID: ibc-107681

RESUMO

Introducción y objetivos: Nuestro objetivo primario es evaluar los factores asociados, las manifestaciones clínicas y el pronóstico de la endocarditis infecciosa adquirida en el entorno hospitalario comparándola con la adquirida en la comunidad y en usuarios de drogas por vía parenteral. Como objetivo secundario se analizan cambios ocurridos en el tiempo en la distribución de la endocarditis infecciosa adquirida en el entorno hospitalario. Métodos: Se realizó un estudio prospectivo observacional y comparativo que incluyó los casos de endocarditis desde enero de 2003 a junio de 2010 y se clasiflcaron en 2 grupos; grupo 1: comunidad y usuarios de drogas por vía parenteral, y grupo 2: adquirida en el entorno hospitalario (nosocomial y nosohusial).Los episodios fueron clasiflcados en 2 periodos (periodo I: enero de 2003-junio de 2006, y periodo II: juliode 2006-junio de 2010). Se efectuó un análisis univariado y multivariado. Resultados: Se incluyeron 212 episodios (grupo 1: 138; grupo 2: 74). La edad (OR, 1,026; IC del 95%,1,003-1,049), el índice de Charlson (OR, 1,242; IC del 95%, 1,067-1,445) y la cirugía cardiaca previa (OR,2,522; IC del 95%, 1,353-4,701) fueron variables asociadas a la endocarditis infecciosa adquirida en el entorno hospitalario en el estudio multivariado. Se observó un incremento no signiflcativo de casos de endocarditis infecciosa adquirida en el entorno hospitalario en el periodo II (40/104; 38,4% vs. 34/108;31,4%).Conclusiones: El incremento reciente de la endocarditis infecciosa adquirida en el entorno hospitalario se asocia sin duda al intervencionismo sobre pacientes mayores, portadores de prótesis valvular cardíaca y que además tienen un mayor número de enfermedades de base, entre las que destaca la insuflciencia renal crónica en hemodiálisis (AU)


Introduction and objectives: The primary aim of this study was to evaluate associated factors, clinical features and prognosis of healthcare-related infective endocarditis cases compared with community acquired and intravenous drug user-related episodes. Changes in the distribution of healthcare-related infective endocarditis were also analysed over time in our setting. Methods: A prospective, observational, comparative study was performed. We included all the cases of infective endocarditis from January 2003 to June 2010, which were then classifled into 2 groups: group 1:community-acquired and intravenous drug user origin, and group 2: nosocomial and non-nosocomial healthcare-related cases. The episodes were classifled into 2 periods: period I: January/2003-June/2006and period II: July/2006-June 2010. Univariate and multivariate analyses were performed. Results: A total of 212 cases were included (group 1: 138, group 2: 74). The variables of age (risk ratio1.026; 95% CI, 1.003 to 1.049), Charlson index (risk radio 1.242; 95% CI, 1.067 to 1.445), and previous heartsurgery (risk ratio 2.522; 95% CI, 1.353 to 4.701) were independently associated with healthcare-related infective endocarditis on multivariate analysis. A non-signiflcant increase was observed in health carerelated cases of infective endocarditis in period II (40/104; 38.4% vs. 34/108; 31.4%).Conclusions: The recent increase in healthcare-related infective endocarditis seems to be associated with the use of invasive procedures in elderly patients with prosthetic cardiac valve, and those with a greater number of underlying diseases, especially patients with chronic renal failure on haemodialysis (AU)


Assuntos
Humanos , Endocardite Bacteriana/epidemiologia , Infecção Hospitalar/epidemiologia , Infecções Comunitárias Adquiridas/epidemiologia , Estudos Prospectivos , Fatores de Risco , Infecções Relacionadas a Cateter/epidemiologia , Fatores Etários
5.
Enferm Infecc Microbiol Clin ; 31(1): 15-22, 2013 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-22652100

RESUMO

INTRODUCTION AND OBJECTIVES: The primary aim of this study was to evaluate associated factors, clinical features and prognosis of healthcare-related infective endocarditis cases compared with community-acquired and intravenous drug user-related episodes. Changes in the distribution of healthcare-related infective endocarditis were also analysed over time in our setting. METHODS: A prospective, observational, comparative study was performed. We included all the cases of infective endocarditis from January 2003 to June 2010, which were then classified into 2 groups: group 1: community-acquired and intravenous drug user origin, and group 2: nosocomial and non-nosocomial healthcare-related cases. The episodes were classified into 2 periods: period I: January/2003-June/2006 and period II: July/2006-June 2010. Univariate and multivariate analyses were performed. RESULTS: A total of 212 cases were included (group 1: 138, group 2: 74). The variables of age (risk ratio 1.026; 95%CI, 1.003 to 1.049), Charlson index (risk radio 1.242; 95%CI, 1.067 to 1.445), and previous heart surgery (risk ratio 2.522; 95%CI, 1.353 to 4.701) were independently associated with healthcare-related infective endocarditis on multivariate analysis. A non-significant increase was observed in healthcare-related cases of infective endocarditis in period II (40/104; 38.4% vs. 34/108; 31.4%). CONCLUSIONS: The recent increase in healthcare-related infective endocarditis seems to be associated with the use of invasive procedures in elderly patients with prosthetic cardiac valve, and those with a greater number of underlying diseases, especially patients with chronic renal failure on haemodialysis.


Assuntos
Infecção Hospitalar , Endocardite , Idoso , Infecções Comunitárias Adquiridas/complicações , Infecções Comunitárias Adquiridas/epidemiologia , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/epidemiologia , Endocardite/diagnóstico , Endocardite/epidemiologia , Endocardite/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Prospectivos , Encaminhamento e Consulta , Abuso de Substâncias por Via Intravenosa/complicações , Centros de Atenção Terciária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...